Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials

A. Blauvelt^*, K. Reich, K. A. Papp, A. B. Kimball, M. Gooderham, S. K. Tyring, R. Sinclair, D. Thaçi, Q. Li, N. Cichanowitz, S. Green, C. La Rosa

^*Korrespondierende/r Autor/-in für diese Arbeit